Chinese Journal of Tissue Engineering Research ›› 2025, Vol. 29 ›› Issue (31): 6688-6696.doi: 10.12307/2025.545

Previous Articles     Next Articles

Lycium barbarum polysaccharide intervenes in SH-SY5Y cell injury induced by beta-amyloid protein 1-42: protective effect of mitochondrial autophagy

Su Qin1, 2, Jia Siwei1, 2, Guo Minfang2, Meng Tao2, Li Yanbing1, 2, Mu Bingtao2, Song Lijuan1, Ma Cungen1, 2, Yu Jiezhong1, 2, 3   

  1. 1Neurobiology Research Center of Shanxi University of Chinese Medicine/Key Research Laboratory of State Administration of Traditional Chinese Medicine for Treatment of Multiple Sclerosis with Replenishing Qi and Huoxue Method, Jinzhong 030619, Shanxi Province, China; 2Institute of Brain Science of Shanxi Datong University/Molecular Cellular Immunology, Datong City Key Laboratory, Datong 037009, Shanxi Province, China; 3Datong Fifth People’s Hospital, Datong 037009, Shanxi Province, China
  • Received:2024-06-27 Accepted:2024-08-31 Online:2025-11-08 Published:2025-02-24
  • Contact: Yu Jiezhong, Professor, Doctoral supervisor, Neurobiology Research Center of Shanxi University of Chinese Medicine/Key Research Laboratory of State Administration of Traditional Chinese Medicine for Treatment of Multiple Sclerosis with Replenishing Qi and Huoxue Method, Jinzhong 030619, Shanxi Province, China; Institute of Brain Science of Shanxi Datong University/Molecular Cellular Immunology, Datong City Key Laboratory, Datong 037009, Shanxi Province, China; Datong Fifth People’s Hospital, Datong 037009, Shanxi Province, China; Co-corresponding author: Ma Cungen, Doctoral supervisor, Neurobiology Research Center of Shanxi University of Chinese Medicine/Key Research Laboratory of State Administration of Traditional Chinese Medicine for Treatment of Multiple Sclerosis with Replenishing Qi and Huoxue Method, Jinzhong 030619, Shanxi Province, China; Institute of Brain Science of Shanxi Datong University/Molecular Cellular Immunology, Datong City Key Laboratory, Datong 037009, Shanxi Province, China
  • About author:Su Qin, Master candidate, Neurobiology Research Center of Shanxi University of Chinese Medicine/Key Research Laboratory of State Administration of Traditional Chinese Medicine for Treatment of Multiple Sclerosis with Replenishing Qi and Huoxue Method, Jinzhong 030619, Shanxi Province, China; Institute of Brain Science of Shanxi Datong University/Molecular Cellular Immunology, Datong City Key Laboratory, Datong 037009, Shanxi Province, China; Jia Siwei, Master candidate, Neurobiology Research Center of Shanxi University of Chinese Medicine/Key Research Laboratory of State Administration of Traditional Chinese Medicine for Treatment of Multiple Sclerosis with Replenishing Qi and Huoxue Method, Jinzhong 030619, Shanxi Province, China; Institute of Brain Science of Shanxi Datong University/Molecular Cellular Immunology, Datong City Key Laboratory, Datong 037009, Shanxi Province, China Su Qin and Jia Siwei contributed equally to this article.
  • Supported by:
    Shanxi Basic Research Program, No. 202303021211244 (to YJZ); Shanxi 2022 "Four Batches" Science and Technology Innovation Program, No. 2022XM33 (to YJZ); Shanxi Traditional Chinese Medicine Research Project, No. 2023ZYYB2042 (to YJZ); State Administration of Traditional Chinese Medicine Research Project, No. 2023ZYYDA2038 (to MCG); 2022 Science and Technology Innovation Team Project of Shanxi University of Chinese Medicine, No. 2022TD2010 (to MCG); The 2022 TCM Research Project Plan of Shanxi Provincial Health Commission, No. 2022ZYYC090 (to MCG); Basic Research Plan Project of Shanxi Province, No. 20210302123476 (to GMF); Platform Plan Project of Datong City, No. 2022082 (to YJZ); Research Project Plan Project of Shanxi Provincial Health Commission, No. 2021168 (to YJZ); Shanxi Provincial Administration of Traditional Chinese Medicine Research Project, No. 2023ZYYB2042 (to YJZ); Shanxi Provincial Key Research Office of Traditional Chinese Medicine, No. zyyyjs2024027 (to YJZ)

Abstract: BACKGROUND: Neurodegenerative diseases are closely related to the imbalance of mitochondrial autophagy regulation. Previous studies by the research group have shown that lycium barbarum polysaccharide has neuroprotective effects, but whether it can improve the damage of SH-SY5Y cells induced by β-amyloid protein 1-42 by regulating mitochondrial autophagy is still unclear. 
OBJECTIVE: To explore the protective effect and mechanism of Lycium barbarum polysaccharide on SH-SY5Y cells induced by β-amyloid protein 1-42.  
METHODS: An Alzheimer's disease cell model was established by inducing SH-SY5Y cells with β-amyloid protein 1-42, and then intervening with Lycium barbarum polysaccharide. SH-SY5Y cells were divided into three groups: control group, β-amyloid protein 1-42 group (20 μmol/L β-amyloid protein 1-42 for 24 hours), and Lycium barbarum polysaccharide group (1 g/L Lycium barbarum polysaccharide was added 1 hour in advance to form a protective effect, and then 20 μmol/L β-amyloid protein 1-42 was added to intervene with Lycium barbarum polysaccharide for 24 hours). CCK8 assay was used to detect cell viability. Mitochondrial membrane potential was detected by JC-1. TUNEL staining was used to detect cell apoptosis. Immunofluorescence and western blot assay were used to detect the expression of synaptic, apoptosis, and mitophagy-related indicators.  
RESULTS AND CONCLUSION: (1) Compared with the control group, the cell viability of the β-amyloid protein 1-42 group decreased (P < 0.05); cell apoptosis rate increased (P < 0.05); mitochondrial membrane potential decreased (P < 0.05); the expressions of pro-apoptotic proteins Bax and Caspase3 increased (P < 0.05); the expression of anti-apoptotic protein Bcl-2 decreased (P < 0.05); the expression levels of synaptic-related proteins Syn and PSD-95 decreased (P < 0.05); the expression levels of mitochondrial autophagy-related proteins Pink1, LC3A/B, Parkin, and Beclin-1 decreased (P < 0.05); and the expression of P62 increased (P < 0.05). (2) Compared with the β-amyloid protein 1-42 group, the cell viability in the Lycium barbarum polysaccharide group was increased (P < 0.05); the apoptosis rate was decreased (P < 0.05); the mitochondrial membrane potential was increased (P < 0.05); the expression levels of Bax and Caspase3 were decreased (P < 0.05); the expression of Bcl-2 was increased (P < 0.05); the expressions of Syn and PSD-95 were increased (P < 0.05); the expression levels of Pink1, LC3A/B, Parkin, and Beclin-1 were increased (P < 0.05), and the expression of P62 was decreased (P < 0.05). These findings indicate that Lycium barbarum polysaccharide may inhibit β-amyloid protein 1-42-induced damage to SH-SY5Y cells by regulating mitophagy, reduce cell apoptosis, and increase neuronal synaptic plasticity. 


Key words: lycium barbarum polysaccharide, Alzheimer’s disease, SH-SY5Y cell, mitophagy, β-amyloid protein, apoptosis, engineered cells

CLC Number: